期刊文献+

肌肉注射大鼠胰岛素原基因治疗糖尿病大鼠的研究 被引量:1

Effect of rat proinsulin gene therapy by intramuscular injection on blood glucose in streptozotocin-induced diabetic rats
暂未订购
导出
摘要 目的:研究肌肉注射大鼠胰岛素原基因重组表达质粒转基因治疗对糖尿病大鼠血糖和胰岛素分泌的影响。方法:链脲佐菌素(STZ)诱导SD大鼠糖尿病模型,经肌肉注射将大鼠胰岛素原基因重组表达质粒pCMV/proinsulin DNA裸质粒直接导入糖尿病大鼠体内,与转染同等剂量pCMV空载质粒的对照组比较,观察糖尿病大鼠血糖的影响以及体内胰岛素表达的变化。结果:①接受肌肉注射重组质粒的治疗组(A组)糖尿病大鼠血糖下降约4mmol/L,且能维持1~2周,血浆胰岛素水平明显升高,并持续表达2周;②肌肉注射胰岛素原基因治疗后,治疗组血糖明显低于接受pCMV空载质粒对照组(B组)和糖尿病对照组(DM组)(P<0.05),治疗组胰岛素浓度也明显高于这两个对照组(P<0.05);③肌肉注射治疗组大鼠的骨骼肌能检测到大鼠胰岛素原基因mRNA的表达,而对照组则为阴性;治疗组大鼠胰腺胰岛素原基因mRNA的表达量也明显高于对照组;④免疫组化结果显示,肌肉注射治疗组大鼠骨骼肌组织可见胰岛素表达,而对照组则无表达;治疗组胰腺组织胰岛素含量较对照组明显增高。结论:糖尿病大鼠裸质粒肌肉注射转基因治疗可获得胰岛素的有效表达,并有效降低糖尿病大鼠的血糖水平。 Objective:To study the effect of rat proinsulin gene therapy by intramuscular injection on blood glucose and insulin secretion in streptozotocin-induced diabetic rats. Methods:Recombinant eukaryotic cell expression plasmid of rat proinsulin gene pCMV/proinsulin was transferred into streptozotocin-induced diabetic rats by intramuscular injection. The treatment group (Group A) was injected with pCMV/proinsulin naked plasmid DNA 100 μg,whereas the corresponding control group(Group B) was treated with similar amount of pCMV DNA. Normal group and DM group were also observed at the same time. Blood glucose levels and plasma insulin levels were determined by hypersensitive radioimmunoassay. RT-PCR was used to determine the alteration of proinsulin mRNA expression in skeletal muscles and pancreas. Sections of skeletal muscles and pancreas in each group were also observed. Results: (1)The blood glucose level in Group A was decreased about 4 mmol/L and maintained for 1-2 weeks. The serum insulin level increased significantly after pCMV/proinsulin gene therapy. The blood glucose in Group A was significantly lower than Group B and DM Group (P 〈 0.05),while serum insulin was higher than that of two groups (P 〈 0.05). (2)Proinsulin mRNA expression could be detected in skeletal muscle cells of Group A, but no detected in that of Group B and DM Group. It was also showed that proinsulin mRNA expression was higher in pancreas of Group A than Group B and DM Group. (3)Immunohistochemistry studies showed that insulin staining was positive in the sections of skeletal muscles of Group A,whereas the same results were not obtained in Group B and DM Group. And insulin staining was more intensive in pancreas of Group A than that of Group B. Conclusion:Direct injection of naked plasmids encoding rat proinsulin gene intramuscularly led to the reduction of blood glucose level, suggesting that proinsulin gene therapy offers a potential approach to diabetes.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2008年第1期42-46,共5页 Journal of Nanjing Medical University(Natural Sciences)
关键词 糖尿病 胰岛素原基因 基因治疗 肌肉注射 裸质粒 diabetes mellitus proinsulin gene gene therapy intramuscular injection naked plasmid
  • 相关文献

参考文献15

  • 1Dieterle C, Brendel MD,Seissler J, et al. Therapy of diabetes mellitus: Pancreas transplantation,islet transplantation, stem cell and gene therapy [ J ]. Internist (Bed), 2006,5 : 489-496,498-501
  • 2Lee HC,Kim SJ, Kim KS,et al, Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue[J]. Nature, 2000,48:482-488
  • 3Inoue H,itakura M. Gene therapy for diabetes mellitus [J]. Nippon Rinsho, 2005,63(Suppl 12) :699-704
  • 4Nir T,Dor Y. How to make pancreatic beta cells-prospects for cell therapy in diabetes [J]. Curr Opin Biotechnol,2005,16:524-529
  • 5Lu YC,Sremini C, Rozengurt E,et al. Release of transgenic human insulin from gastric g cells:a novel approach for the amelioration of diabetes [J]. Endocrinology, 2005,146: 2610-2619
  • 6Park YM,Woo S,Lee GT,et al. Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats [J]. J Gene Med, 2005,7 : 621-629
  • 7蒋琳,季旻珺,吴海玮,贾悦,唐伟,刘翠萍,张兆松,刘超.糖尿病的基因治疗技术:大鼠胰岛素原基因真核细胞表达质粒构建与鉴定[J].中国临床康复,2004,8(27):5844-5846. 被引量:2
  • 8Yin D,Tang JG. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo [J]. FEBS Lett, 2001,495 : 16-20
  • 9Koh JJ, Ko KS, Lee M, et al. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice [J]. Gene Ther,2000,7: 2099-2104
  • 10Contreras JL,Bilbao G,Smyth C,et al. Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement[J]. Surgery,2001,130:166-174

二级参考文献51

  • 1金冬雁 黎孟枫 等.分子克隆实验指南(第2版)[M].科学出版社,1993.24.
  • 2Saudek F.Gene therapy in the treatment of diabetes mellitus.Cas Lek Cesk 2003;142(9):523- 7
  • 3Chan L,Fujimiya M,Kojima H.In vivo gene therapy for diabetes mellitus.Trends Mol Med 2003;9(10):430- 5
  • 4Oka K,Chan L.Liver-directed gene therapy for dyslipidemia and diabetes.Curr Atheroscler Rep 2004;6(3):203- 9
  • 5Song S,Goudy K,Campbell-Thompson M,et al.Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice.Gene Ther 2004;11(2):181- 6
  • 6Ajamian F,Titok T,Suhorada E,et al.Hepatic expression of the human insulin gene reduces glucose levels in vivo in diabetic mice model.Diabetes Metab 2003;29(4 Pt 1):424- 9
  • 7Kolodka TM,Finegole M,Moss L,et al.Gene therapy for diabetes mellitus in rats by hepatic expression of insulin.Proc Natl Acad Sci USA 1995;92:3293- 7
  • 8Stewart C,Taylor NA,Green IC,et al.Insulin-releasing pituitary cells as a model for somatic cell gene therapy in diabetes mellitus.J Endocrinol 1994;142(2):339- 43
  • 9Docherty K,Clark AR,Scott V,et al.Metabolic control of insulin gene expression and biosynthesis.Proc Nutr Soc 1991;50(3):553- 8
  • 10Kawakami Y, Yamaoka T,Hirochika R,et al.Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells.Diabetes 1992;41:956- 61

共引文献2

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部